AKT1 and cancer: The RNA-seq results in our study indicated that sodium butyrate treatment activated the PI3K/AKT signaling pathway in U251 cells (Figure 2C), and GSEA revealed that the differentially expressed genes were involved in PD-L1 expression and the PD-1 checkpoint pathway in cancer (Figure 2E).